Free tool
FAERS Monitor: Pred Forte
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017011 or its brand name (Pred Forte, Prednisolone Acetate). Reports on generic versions are filed under their own applications.
Reports
11,227
Serious
5,507
49% of reports
Hospitalization
2,080
Death reported
577
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- treatment failure1,267
- drug ineffective945
- eye pain791
- recalled product administered764
- off label use735
- no adverse event677
- eye irritation471
- vision blurred465
- headache382
- fatigue379
- ocular hyperaemia336
- diarrhoea301
- pain288
- condition aggravated287
- cataract285
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 37 |
| 2005 | 71 |
| 2006 | 94 |
| 2007 | 109 |
| 2008 | 168 |
| 2009 | 111 |
| 2010 | 171 |
| 2011 | 148 |
| 2012 | 279 |
| 2013 | 200 |
| 2014 | 268 |
| 2015 | 405 |
| 2016 | 649 |
| 2017 | 439 |
| 2018 | 527 |
| 2019 | 604 |
| 2020 | 1,786 |
| 2021 | 562 |
| 2022 | 683 |
| 2023 | 757 |
| 2024 | 819 |
| 2025 | 933 |
| 2026 | 1,407 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,932 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| recalled product administeredSignal | 764 | 163.0 | 151.8 | 113,095 |
| treatment failureSignal | 1,267 | 29.1 | 27.6 | 33,936 |
| eye painSignal | 791 | 26.6 | 24.9 | 19,260 |
| eye irritationSignal | 471 | 15.4 | 14.1 | 6,316 |
| ocular hyperaemiaSignal | 336 | 13.4 | 12.0 | 3,808 |
| cataractSignal | 285 | 9.0 | 8.0 | 2,016 |
| no adverse eventSignal | 677 | 7.0 | 6.5 | 3,508 |
| vision blurredSignal | 465 | 6.4 | 5.8 | 2,103 |
| condition aggravated | 287 | 1.8 | 1.6 | 97 |
| off label use | 735 | 1.6 | 1.5 | 159 |
| drug ineffective | 945 | 1.3 | 1.3 | 88 |
| headache | 382 | 1.1 | 1.0 | 7 |
| fatigue | 379 | 0.9 | 0.8 | 3 |
| pain | 288 | 0.9 | 0.8 | 5 |
| diarrhoea | 301 | 0.9 | 0.8 | 6 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.